Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1995 3
1996 2
1997 14
1998 16
1999 9
2000 13
2001 10
2002 10
2003 17
2004 14
2005 23
2006 13
2007 13
2008 10
2009 6
2010 9
2011 6
2012 8
2013 11
2014 15
2015 15
2016 10
2017 13
2018 17
2019 17
2020 23
2021 36
2022 26
2023 22
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

366 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
Reply.
Findl O, Brás JEG, Sickenberger W, Hirnschall N. Findl O, et al. J Cataract Refract Surg. 2019 Jun;45(6):894. doi: 10.1016/j.jcrs.2019.04.013. J Cataract Refract Surg. 2019. PMID: 31146953 No abstract available.
Anterior Segment OCT.
Asam JS, Polzer M, Tafreshi A, Hirnschall N, Findl O. Asam JS, et al. Among authors: findl o. 2019 Aug 14. In: Bille JF, editor. High Resolution Imaging in Microscopy and Ophthalmology: New Frontiers in Biomedical Optics [Internet]. Cham (CH): Springer; 2019. Chapter 13. 2019 Aug 14. In: Bille JF, editor. High Resolution Imaging in Microscopy and Ophthalmology: New Frontiers in Biomedical Optics [Internet]. Cham (CH): Springer; 2019. Chapter 13. PMID: 32091839 Free Books & Documents. Review.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.
Reply.
Hirnschall N, Leisser C, Radda S, Findl O. Hirnschall N, et al. Among authors: findl o. J Cataract Refract Surg. 2016 Oct;42(10):1545. doi: 10.1016/j.jcrs.2016.08.022. J Cataract Refract Surg. 2016. PMID: 27839625 No abstract available.
Online intraocular lens calculation.
Buonsanti D, Raimundo M, Findl O. Buonsanti D, et al. Among authors: findl o. Curr Opin Ophthalmol. 2024 Jan 1;35(1):11-16. doi: 10.1097/ICU.0000000000001014. Epub 2023 Nov 3. Curr Opin Ophthalmol. 2024. PMID: 37922421 Review.
366 results